Literature DB >> 9649344

Formulation-related problems associated with intravenous drug delivery.

S H Yalkowsky1, J F Krzyzaniak, G H Ward.   

Abstract

Mesh：

Year:  1998        PMID： 9649344     DOI： 10.1021/js980051i

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  9 in total

1.  Composition optimization and stability testing of a parenteral antifungal solution based on a ternary solvent system.

Authors:  Kristóf Kovács; István Antal; György Stampf; Imre Klebovich; Krisztina Ludányi
Journal:  AAPS PharmSciTech       Date:  2010-02-24       Impact factor: 3.246

2.  Emulsifiers' composition modulates venous irritation of the nanoemulsions as a lipophilic and venous irritant drug delivery system.

Authors:  Chengwen Mao; Jiangling Wan; Huabing Chen; Huibi Xu; Xiangliang Yang
Journal:  AAPS PharmSciTech       Date:  2009-08-11       Impact factor: 3.246

3.  Microparticles and Nanoparticles Delivered in Intravenous Saline and in an Intravenous Solution of a Therapeutic Antibody Product.

Authors:  Neha N Pardeshi; Wei Qi; Kevin Dahl; Liron Caplan; John F Carpenter
Journal:  J Pharm Sci       Date:  2016-11-07       Impact factor: 3.534

Review 4.  Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.

Authors:  Anil Kumar; Fei Chen; Anbu Mozhi; Xu Zhang; Yuanyuan Zhao; Xiangdong Xue; Yanli Hao; Xiaoning Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanoscale       Date:  2013-09-21       Impact factor: 7.790

5.  Intravenous Pharmacokinetics, Local Tolerability, and Hemolysis of an SBE7-β-Cyclodextrin Formulation of the Neurokinin-1 Receptor Antagonist Vestipitant.

Authors:  Richard A Brigandi; Steven F Russ; Chantal Petit; Brendan Johnson; Scott Croy; Peter Hodsman; Fran Muller
Journal:  Clin Pharmacol Drug Dev       Date:  2014-05-26

6.  Effect of the excipient concentration on the pharmacokinetics of PM181104, a novel antimicrobial thiazolyl cyclic peptide antibiotic, following intravenous administration to mice.

Authors:  Vijayaphanikumar Yemparala; Anagha A Damre; Venkat Manohar; Kishori Sharan Singh; Girish B Mahajan; Satish N Sawant; Tanaji Deokule; H Sivaramakrishnan
Journal:  Results Pharma Sci       Date:  2014-09-10

7.  Subtilisin QK-2: secretory expression in Lactococcus lactis and surface display onto gram-positive enhancer matrix (GEM) particles.

Authors:  Ruifeng Mao; Kangping Zhou; Zhenwei Han; Yefu Wang
Journal:  Microb Cell Fact       Date:  2016-05-12       Impact factor: 5.328

8.  An improved method to prepare an injectable microemulsion of the galanin-receptor 3 selective antagonist, SNAP 37889, using Kolliphor(®) HS 15.

Authors:  Karlene J Scheller; Spencer J Williams; Andrew J Lawrence; Bevyn Jarrott; Elvan Djouma
Journal:  MethodsX       Date:  2014-09-26

9.  Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts.

Authors:  Satish Patil; Lev G Lis; Robert J Schumacher; Beverly J Norris; Monique L Morgan; Rebecca A D Cuellar; Bruce R Blazar; Raj Suryanarayanan; Vadim J Gurvich; Gunda I Georg
Journal:  J Med Chem       Date:  2015-11-24       Impact factor: 7.446
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.